LMAT
LEMAITRE VASCULAR INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$78.87
−0.76%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $0.69
- Revenue estimate
- $67.4M
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- $0.74
- EPS estimate
- $0.81
- Revenue actual
- $70.4M
- Revenue estimate
- $71.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +1.5%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | $0.81 | $0.74 | Miss -8.30% | $70.4M |
| May 5, 2026 | $0.66 | $0.68 | Beat 3.03% | $66.6M |
| Feb 25, 2026 | $0.67 | $0.68 | Beat 1.49% | $64.5M |
| Nov 6, 2025 | $0.56 | $0.62 | Beat 9.93% | $61.0M |
| May 1, 2025 | $0.50 | $0.48 | Miss -4.57% | $59.9M |
| Feb 27, 2025 | $0.49 | $0.49 | Miss -0.41% | $55.7M |
| Oct 31, 2024 | $0.44 | $0.49 | Beat 11.11% | $54.8M |
| Aug 1, 2024 | $0.47 | $0.52 | Beat 10.40% | $55.8M |
| May 2, 2024 | $0.39 | $0.44 | Beat 13.11% | $53.5M |
| Feb 27, 2024 | $0.36 | $0.38 | Beat 6.15% | $48.9M |
| Nov 1, 2023 | $0.30 | $0.33 | Beat 10.37% | $47.4M |
| Aug 1, 2023 | $0.32 | $0.36 | Beat 12.85% | $50.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026